Josef J. Geldwert, DMP of the "Center for Podiatric Care and Sports Medicine" of New York, hasn't doubts: MLS® is the most safe and effective therapy that might be available to treat common diseases in his daily practice. «I've got the chance to use MLS® on different patients in various conditions – said the doctor in a recent interview to "Profile in Excellence 2013” - and I had to yield to the evidence: the results were tangible and observable since the first applications. The same patients were impressed for the rapidity of the treatment and the absence of any type of contraindication». For the doctor, also the scientific and clinical studies developed as support for therapy represent a benefit. «I am deeply convinced that MLS® is safe and effective, the perfect solution for my everyday activity». Plantar fasciitis, tendonitis, overuse injuries, ankle sprains and fractures are some of the diseases treated with ASAlaser's therapy, collecting outcomes always positive. «As sportsman, I also used MLS® on myself to relieve some stiffness encountered during training. The results were excellent». In the experience gained on stage by the doctor, the therapy is providential not only to solve sports problems, but also to treat arthritis cases, common in older patients. «In these specific situations - concludes Dr. Geldwert - we have verified that MLS® is very functional to significantly moderate symptoms associated with the disease degeneration. Even in the treatment of acute injuries, as in the case of ankle sprain, therapy is very effective in reducing pain and inflammation in quick time. I am amazed to discover how the application of MLS® is not only very appropriate, but also decisive in many areas».
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.